SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-007955
Filing Date
2022-03-29
Accepted
2022-03-29 08:30:14
Documents
12
Period of Report
2022-03-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35081
  Complete submission text file 0001493152-22-007955.txt   206459

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE yewb-20220328.xsd EX-101.SCH 3042
3 XBRL LABEL FILE yewb-20220328_lab.xml EX-101.LAB 35156
4 XBRL PRESENTATION FILE yewb-20220328_pre.xml EX-101.PRE 23035
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3458
Mailing Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Business Address 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731 626-401-9588
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54701 | Film No.: 22777511
SIC: 0100 Agricultural Production-Crops